User:Cecilia Cisar/Notebook/Mod 3 Research Proposal

From OpenWetWare
< User:Cecilia Cisar | Notebook
Revision as of 22:37, 5 May 2014 by Cecilia Cisar (talk | contribs) (→Project Description/Abstract)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Project Description

  • To design bacteria that use specific miRNA signatures to target cancer cells.
  • Overview for this assignment and FAQ

Overview

  • During certain stages of growth, cancer cells exhibit unique miRNA signatures.[1]
  • Some organisms use miRNA to target and inhibit sections of bacterial DNA.[2]

References

  1. Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.
  2. Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ."Nature immunology 12.9 (2011): 861-869.
Recently Edited Notebook Pages
  • 2017-09-27 06:56:17 User:Cecilia Cisar/Notebook/Mod 3 Research Proposal/Entry Base
Retrieved from "https://openwetware.org/mediawiki/index.php?title=User:Cecilia_Cisar/Notebook/Mod_3_Research_Proposal&oldid=792202"
Category:
  • Pages using DynamicPageList3 parser function

Navigation menu

Page actions

  • User page
  • Talk
  • Read
  • View source
  • History
  • Refresh

Page actions

  • User page
  • Talk
  • More
  • Tools

Personal tools

  • Log in
  • Request account

Navigation

  • Main Page
  • Recent changes
  • Help
  • Contact OWW
  • Add a Lab Notebook
  • Special pages

research

  • Materials
  • Protocols
  • Resources

Tools

  • What links here
  • Related changes
  • User contributions
  • Logs
  • View user groups
  • Printable version
  • Permanent link
  • Page information
  • Browse properties
Powered by MediaWiki
Powered by Semantic MediaWiki
  • This page was last edited on 5 May 2014, at 22:37.
  • Content is available under GNU FDL or Creative Commons BY-SA unless otherwise noted.
  • About OpenWetWare
  • Disclaimers
  • Mobile view